|
Zestagen SA Zestagen SA is a biotechnology company focusing on the discovery and development of monoclonal antibodies against human disease. www.zestagen.com More information |
|
Microvu Present for several years in the middle of the distribution of dimensional equipment of metrology, Microvu opened a new department of service closer to these customers. Our dimensional laboratory of metrology and calibration is at your disposal to answer your needs of controls and advice. The quality of our service, a High-tech equipment, an expertise in metrology, the flexibility and the versatility of our team will allow to propose you a help adapted to your domain in metrology.www.microvu.ch More information |
|
ISREC Foundation Founded in 1964, the ISREC Foundation is a non-profit organization, under Swiss Federal supervision. The ISREC Foundation selects and supports cancer research projects that help the transfer of knowledge and collaboration between fundamental research and clinical research: the translational research. The goal of these projects is to provide new paths to novel therapies and clinical approaches, as well as to explore cells and their interactions with their environment in order to act on the causes of ... More information |
|
Stemedica International SA Stemedica International S.A. (Lausanne, CH), is a subsidiary of Stemedica Cell Technologies Inc. (San Diego, USA). The company is committed to manufacturing cGMP (current Good Manufacturing Practice) adult stem cells and developing products for regenerative medicine. Stemedica's adult stem cell technology is based on thirty years of research and clinical experience conducted by researchers and clinicians in the former Soviet Union, Europe and the United States. The technology and scientific know-how ... More information |
|
Mymetics Founded in 2000, Mymetics Corporation is an American biotechnology company with its Executive office in Switzerland. Since 2004 it has focused on the development of a new generation of vaccines. Mymetics is poised to become the leader in the development of proprietary vaccines that focus on the mucosal layer to develop protection against infections using an innovative, safe and effective delivery platform called virosomes. Mymetics currently has five vaccines in development targeting infectious ... More information |
| 1 2 3 4 > >> |